维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

19篇 您的检索式：作者名="Shettigar"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Elevated micronuclei frequen- cy in type 2 diabetes with high glycosylated hemoglobin 显示文摘	Shettigar SKG ShailajaC KulkarniRK	2012	Diabetes re- search and clinical practice2012，95，2：	1
	2	A portable hemodialysis/ hemofiltration system independent of dialysate and infusion fluid显示文摘	Shettigar UR	1983	Artif Organs1983，7，：	1
	3	Clinical effects of esmoLol,a ultra-short acting β-adrenerglc blocking agent显示文摘	Barbier GH Shettigar UR Appunn DO	1995	Int J Clin Pharmacol Ther1995，33，：	1
	4	Clinical rationale for theuse of an ultra-short acting beta-blocker:esmolol显示文摘	Barbier GH Shettigar UR Appunn DO	1995	Int J Clin Pharmacol Ther1995，33，16：	1
	5	plasma sialidase activity in acuye myocardial infarction 显示文摘	Hanson VA Shettigar VR Loungani RR	1987	Am Heart j1987，114，1：	1
	6	Investigation of third-order nonlinear and optical power limiting properties of terphenyl derivatives 显示文摘	KAMATH L MANJUNATHA K B SHETTIGAR S	2014	Optics g Laser Technology2014，56，：	1
	7	Clinical rationale for the use of an ultrashort acting beta-blocker: esmolol显示文摘	SHETTIGAR UR APPUNN DO	1995	Int J Clin Pharmacol Ther1995，33，4：	1
	8	Clinical application of supershort acting B-receptor blocker esmolol显示文摘	Arbier G H Shettigar L I R APPUnn Do	1995	Int J Clin Pharmacol Ther1995，33，：	1
	9	Adverse effects of sublingual nifedip- ine in acute myocardial infarction显示文摘	Shettigar UR Loungani R	1989	Crit Care Med1989，17，2：	1
	10	Clinical application of supershort acting β2 receptor blocker esmolol显示文摘	Arbier GH Shettigar UR Appunn DO	1995	Int J Clin Pharmacol Ther1995，33，：	1
	11	Occult atrial septal defect in adults显示文摘	Shettigar UR Hultgren HN Berndt T	1975	Chest1975，68，3：	1
	12	Clinical application of supershort acting β-receptor blocker esmolol显示文摘	Arbier GH Shettigar UR Appunn DO	1995	Int J Clin Pharmacol Ther1995，33，：	1
	13	Clinical application of super short acting -receptor blocker esmolol显示文摘	ARBIER GH SHETTIGAR UR APPUNN DO	1995	Int J Clinical Pharmacology Ther1995，33，：	1
	14	Clinical application of supershort acting β-receptor blocker esmolol显示文摘	ARBIER G H SHETTIGAR U R APPUNN D O	1995	Int J Clin Pharmacol Ther1995，33，：	1
	15	Clinical rationale for the use of an ultra-short acting beta-blocker:esmolol显示文摘	Barbier GH Shettigar UR Appunn DO	1995	Int J Clin Pharmacol Ther1995，33，4：	1
	16	Clinical rationale for the use of an ultra-short acting beta-blocker:esmolol显示文摘	Shettigar UR Appunn DO	1995	Int J Clin Pharmacol Ther1995，33，4：	1
	17	Clinical application of super short acting 13 -receptor blocker esmolol显示文摘	Arbier G Shettigar U Appunn D	1995	Int J ClinPharmacolTher1995，33，：	1
	18	Clinical application of supershort acting β-receptor blocker esmolol 显示文摘	ARBIER GH SHETTIGAR UR APPUNN DO	1995	Int J Clin Pharmacol Ther1995，33，4：	1
	19	Role of phase separation in nanocomposite indium-tin-oxide films for transparent thermoelectric applications显示文摘We report that oxygen vacancies have a profound impact on phase separation and thermoelectric properties of ITO films grown at room temperature.Oxygen vacancies in non-stoichiometric In1.8Sn0.2O2.5 films aided the formation of In-rich metallic clusters.It yields a high electrical conductivity s=1540 Scm1 and Seebeck coefficient\|a\|=27.2 mVK1,which resulted in the highest power factor(a2 s=113.8 mW m1 K2)but low optical transmission(Top-25%).An increase in oxygen partial pressure resulted in stochiometric In1.8Sn0.2O3 films which improved the optical transparency by 300%(Top-75.4%),but power factor was reduced by-85%due to a decrease in a and s.A decrease in a was due to the lack of energy filtering of charge carriers in the stoichiometric ITO film which did not have In-rich metallic clusters.XPS results showed that the valence band energy shifts with a change in oxygen partial pressure due to a decrease in carrier density,which implied a change in Fermi energy due to the reverse Moss-Burstein effect.Our results showed that phase separation can be obtained in nanocomposite ITO films by tuning their stoichiometry simply by varying the oxygen partial pressure during deposition of thermoelectric materials at low temperatures.	Peter P.Murmu Akhil Shettigar Shen V.Chong Zihang Liu Dana Goodacre Vedran Jovic Takao Mori Kevin E.Smith John Kennedy	2021	Journal of Materiomics2021，7，3：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费